3E Bioventures Capital L.P. 13D and 13G filings for Cytek Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-03 5:26 pm Sale | 2022-08-03 | 13G | Cytek Biosciences, Inc. CTKB | 3E Bioventures Capital L.P. | 5,684,615 4.230% | -4,002,250 (-41.32%) | Filing |
| 2022-02-16 6:27 pm Purchase | 2021-12-31 | 13G | Cytek Biosciences, Inc. CTKB | 3E Bioventures Capital L.P. | 9,686,865 7.240% | 9,686,865 (New Position) | Filing |